Excellent

Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022
Holiday, OHSU, Patient, Oregon Health & Science University, Oregon Health and Science University Center for Women's Health, Excellent, Pons, HSDT, NYU Langone Health, PTS, Massachusetts General Hospital, TEP, Research, MGH Institute of Health Professions, Growth, PTAP, Therapy, Pharmaceutical industry, Video game, Helios

NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2022.

Key Points: 
  • NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2022.
  • It was the first full quarter of commercial sales and the market response to PoNS Therapy remains strong, as demonstrated by the quarter over quarter increase in US sales.
  • Product sales in the U.S. during the third quarter totaling $139 thousand more than doubled over the second quarter 2022 levels.
  • Operating expenses for the third quarter of 2022 increased to $4.9 million, compared to $4.4 million in the third quarter of 2021.

Cloud4C Achieves AWS DevOps Competency Status

Retrieved on: 
Thursday, November 24, 2022
Cloud, Artificial Intelligence for IT Operations, DevOps, Microsoft Azure, SAP, Architecture, Micro ISV, Google Cloud, Excellent, Amazon Web Services, Microsoft, SLA, AWS, Azure, Video game console, Computer security

SINGAPORE, Nov. 23, 2022 /PRNewswire/ --Cloud4C, a globally leading cloud specialist for mission-critical environments, announced today that it has achieved Amazon Web Services (AWS) DevOps Competency status.

Key Points: 
  • SINGAPORE, Nov. 23, 2022 /PRNewswire/ --Cloud4C, a globally leading cloud specialist for mission-critical environments, announced today that it has achieved Amazon Web Services (AWS) DevOps Competency status.
  • Achieving the AWS DevOps Competency differentiates Cloud4C as an AWS Partner that provides demonstrated expertise in CI-CD deployment and integration, code lifecycle management including monitoring and logging, performance management, Infrastructure-as-Code consulting, and security advancement for development processes.
  • "Cloud4C is proud to achieve AWS DevOps Competency status," lauds Deb Deep Sengupta, President and CRO of Cloud4C.
  • To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify AWS Partners with deep industry experience and expertise.

Nividous Achieves ISO/ IEC 27001:2013 certification for Information Security Management Systems

Retrieved on: 
Friday, November 18, 2022
Automation, Excellent, ISMS, Phare de Nividic, RPA, Risk management, Organization, Documentation, CIA, BPM, ISO/IEC 27001:2013, GDPR, Confidentiality, Certification, Policy, AI

"Becoming an ISO/IEC 27001:2013 certified company showcases our commitment to effective security management system implementation and continuous improvement.

Key Points: 
  • "Becoming an ISO/IEC 27001:2013 certified company showcases our commitment to effective security management system implementation and continuous improvement.
  • ISO 27001, the world's best-known standard for information security management systems (ISMS), indicates an organization's alignment with information security best practices.
  • We at Nividous apply a holistic approach to securing the confidentiality, integrity, and availability (CIA) of Nividous' information assets.
  • Our risk management strategies, unique to each department, are designed by keeping the information security standards at the center of our business processes, systems, and controls.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson's and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

Retrieved on: 
Thursday, November 17, 2022
Parkinson's Foundation, SAN, Excellent, ESourcing Capability Model, Neurology, CRO, Movement disorders, Technology, Gastroenterology, Parkinson, Partnership, Vial, Dermatology, University, Industry, Ophthalmology, Cardiology, Children's Mercy Hospital, Research, Multimedia, EDC, EPRO, Cras, Patient, University of Kansas Medical Center, Parkinson's disease, CNS, Central nervous system, Faculty, Digital technology, Fine chemical

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO .

Key Points: 
  • SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO .
  • Dr. Pahwa joins fellow Vial scientific board members, Dr. Robert Hauser and Dr. Joseph Jankovic .
  • On the partnership, Dr. Pahwa shared, "I am delighted to join Vial's scientific advisory board and contribute to the evolution of their Neurology CRO.
  • Vial operates across multiple therapeutic areas ( Dermatology CRO , Ophthalmology CRO , Oncology CRO , Gastroenterology CRO , Neurology CRO , and Cardiology CRO ).

Akeyless raises $65M to provide Secrets Management as-a-Service for DevOps and multi-cloud environments

Retrieved on: 
Wednesday, November 16, 2022
Zero, Knowledge, Cloud, CYBR, JVP, Pain, F500, Technology, NGP, General partnership, Secrecy, Software, Entrepreneurship, Industry, Center, Ownership, Adoption, Capital, BMW, Solution, Excellent, VC, Partnership, DevOps, NIST, TEL, CA Technologies, Software as a service, Science and technology in Asia, CEO, DFC, Partner (business rank), AI, Jerusalem Venture Partners, Chief executive officer, Nokia, CyberArk, Environment, Maintenance, Organization, Security, Team8, Unit, CISO-FM, Seed, COO, Computer security, Fortune 500, CIOS, MINI, University, Growth, Preqin, NEW, Group, Budget, Digital transformation, NASDAQ, TCO, Cryptocurrency, Risk management, Renewable energy, Management, Public relations, Outbrain

NEW YORK and TEL AVIV, Israel, Nov. 16, 2022 /PRNewswire/ -- Akeyless, the leading SaaS-based Secrets Management Platform for securing DevOps and IT workloads within hybrid and multi-cloud environments, today announced $65 million in series B funding, bringing the total funding to date to $80 million. The round was led by NGP Capital, with participation from existing investors Team8 Capital and Jerusalem Venture Partners (JVP). In addition, the company announced that Mike Christenson, the former COO & President of New Relic and CA Technologies, has joined as an investor and board member.

Key Points: 
  • "Existing secrets management solutions don't meet the current needs of enterprises," said Oded Hareven, CEO and co-founder of Akeyless.
  • Akeyless is the only platform to offer a true zero-knowledge Secrets Management as-a-Service solution.
  • Akeyless centralizes the management and security of secrets across multi-cloud and DevOps environments.
  • Akeyless stores customer secrets and makes them easily accessible in all their environments, while its patented Distributed Fragments Cryptography (DFC) technology makes the secrets inaccessible to anyone besides the customer Akeyless included.

New KUBRA Research Finds Customer Experience Is Top Factor When Choosing an Insurance Provider

Retrieved on: 
Tuesday, November 15, 2022
Health, Government, Solution, Senior, Marketing, Time, Insurance, Intelligence, Research, Investment, Hearst, Policy, Hearst Communications, Excellent, Payment, Life, Research report, Health insurance, Online shopping

TEMPE, Ariz., Nov. 15, 2022 /PRNewswire-PRWeb/ -- KUBRA, a leading provider of customer experience management solutions for some of the largest government, utility, and insurance entities, recently released a research report focused on insured billing and payment trends to help insurers determine which investments will have the most impact on customer satisfaction.

Key Points: 
  • Key findings of KUBRA's Insured Billing and Payment Report 2022 include:
    46% of respondents stated that Customer Experience is a top factor when selecting an insurance provider.
  • A meager 18% of insureds rated their online experience with insurance agencies as "Excellent," showing many opportunities for improvement.
  • KUBRA provides customer experience management solutions to some of the largest utility and government entities across North America.
  • With more than 1.5 billion customer interactions annually, KUBRA services reach over 40% of households in the U.S. and Canada.

InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022

Retrieved on: 
Thursday, November 10, 2022
General Health, Health, Medical Supplies, Medical Devices, ITS, Forward-looking statement, NYSE, Form 10-Q, Risk, Annual report, COVID-19, Securities Act of 1933, Share repurchase, Excellent, Securities Exchange Act of 1934, Sheraton New York Times Square Hotel, Contract, Company, Form 10-K, Conference, Employee Retirement Income Security Act of 1974, Pain management, Lymphedema, Risk management

The conference will be held at the Sheraton New York Times Square in New York City.

Key Points: 
  • The conference will be held at the Sheraton New York Times Square in New York City.
  • Investors interested in arranging one-on-one meetings should contact your Craig-Hallum conference representative.
  • Conversely, you may also call or email Lytham Partners at 602-889-9700, or [email protected] .
  • InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers.

Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Forward-looking statement, Northwestern Health Sciences University, Center, Rehabilitation, Nasdaq, Research, Education, Health, Therapy, Private Securities Litigation Reform Act, Sale, Multiple sclerosis, Tongue, Pons, Neurology, International Classification of Functioning, Disability and Health, COVID-19, Traumatic brain injury, Helios, FAAN, MCR, Brain, News, Securities and Exchange Commission (Philippines), HSDT, Excellent, Gait, Time, Internet, Management of multiple sclerosis, Oregon Health & Science University, FANA, Company, Contract, Maintenance, Medicare, Patient, TEP, OHSU, MS, MD, Regulation, FDA, Pharmaceutical industry, Medical device, Medical imaging, Medicaid

NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the addition of Oregon Health & Science University (OHSU) to its Therapeutic Experience Program (TEP).

Key Points: 
  • NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the addition of Oregon Health & Science University (OHSU) to its Therapeutic Experience Program (TEP).
  • This initiative will be led by Vijayshree Yadav, MD, MCR, FANA, FAAN, Professor of Neurology and OHSU Multiple Sclerosis Center Director.
  • A significant portion of MS patients suffer from gait deficit and PoNS therapy provides a unique opportunity to improve gait functionality and mobility.
  • Oregon Health & Science University is Oregon's only academic health center and distinguished nationally as a research university dedicated solely to advancing health sciences.

Seer Reports Third Quarter 2022 Financial Results

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Seer, Proteome, Private Securities Litigation Reform Act, Forward-looking statement, Protein, Chair, Investment, U.S. Securities and Exchange Commission, SP100, Research, Advanced Materials, Technology, Proteomics, SEC, Goal, Excellent, Machine learning, Software, Company, Automation, Security (finance), Video game

REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2022.
  • Gross profit was $1.9 million and gross margin was 49% for the third quarter of 2022.
  • Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
  • Seer will host a conference call to discuss the third quarter financial results on Tuesday, November 8, 2022 at 1:30 pm Pacific Time / 4:30 pm Eastern Time.

Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results

Retrieved on: 
Wednesday, November 9, 2022
Technology, Mobile, Wireless, Hospitals, Software, Physical Therapy, Internet, Health, General Health, Data Management, Director, Projection, Forward-looking statement, Marketing, Investment, Survivor, Center, Rehabilitation, Ascending limb of loop of Henle, Research, Laboratory, Robotics, Technology, Total, Board, COVID-19, SEC, Solution, Excellent, Public expenditure, Company, Government, Terminology, GAAP, Patient, Growth, Acquisition, Stroke, Income, Medical device, Risk management, Video game, Reinsurance

Richard Russo, President and Chief Executive Officer of Bionik, commented, Bionik achieved several milestones during the second fiscal quarter.

Key Points: 
  • Richard Russo, President and Chief Executive Officer of Bionik, commented, Bionik achieved several milestones during the second fiscal quarter.
  • Total revenue for the second fiscal quarter was $0.5 million, an increase of 113%, compared with $0.2 million revenue in the second quarter of fiscal 2022.
  • Gross profit for the second fiscal quarter was $0.3 million, an increase of 102%, compared to $0.2 million in the second quarter of fiscal 2022.
  • Total operating expenses for the second fiscal quarter were $1.4 million, an increase of 19%, compared to $1.2 million in the second quarter of fiscal 2022.